ArticleScientific reports2026
Validation of the modified transplant symptom occurrence and symptom distress scale and exploring symptom burden in Brazilian kidney transplant recipients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Kidney transplant recipients (KTR) may experience burdensome symptoms, including tremor, nausea, and bruises, sometimes caused by immunosuppressive medication, which can negatively influence health-related quality of life. The 59-item Revised Modified Transplant Symptom Occurrence and Symptom Distress scale (MTSOSD-59R) captures patients' symptom experience but has not been validated in Brazil. We evaluated the Brazilian Portuguese MTSOSD-59R regarding content validity (expert panel), internal structure (factor analysis), and associations with other variables (known-groups approach). Symptom occurrence and distress by sex and age were assessed using ridit analyses. 485 KTR (42.2% women; 50.2 ± 12.8 years) were included at median 7.4 [3.2-13.0] years post-transplantation. The expert-rated scale-content validity index was 0.49. Construct validity and known-group associations were confirmed. The most occurring symptoms were anxiety [ridit score: 0.697], tiredness [0.653], and difficulty seeing well [0.652]. The most distressing symptoms were menstrual problems [0.635], difficulty seeing well [0.606], and genital warts [0.595]. Female/younger KTR tended to report more (distress from) psychological/aesthetic symptoms; male/older KTR tended to report more (distress from) physical symptoms. The MTSOSD-59R showed validity for internal structure and relationships to other variables, but insufficient expert-rated content validity for immunosuppression-specific side effects, suggesting it may better reflect general symptom burden in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.